• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Radioconjugate Therapy: The Approval Process And the Market Landscape Suzanne Elvidge
    August 22, 2025
    Radioconjugates​​ combine ​​targeted ligands​​ with radioisotopes, enabling precision cancer therapy and theranostics. The ​​$7.5B market by 2033​​ demands strict FDA ​​safety/CMC data​​ for NDA/BLA approval.
  • Radioconjugates: Targeting for Precision Suzanne Elvidge
    May 06, 2025
    The development of radioconjugates – targeted molecules designed to carry radionuclides directly to cancerous cells, lowering systemic exposure and increasing the precision of treatment.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service